Anuj Malhotra MD, FSIR, RPVI
@Anuj_MalhotraMD
Followers
2K
Following
2K
Media
28
Statuses
879
Chief - Vascular & Interventional Radiology @NYU Langone LIH. formerly @WeillCornell_IR - @AlbanyIR trained #Venous #PortalHtn #InterventionalOncology
New York, NY
Joined January 2016
To TIPS or not to TIPS? Up next on BackTable, @BenjaminMayMD1 shares his expertise on best practices in Acute Portal Vein Thrombosis treatment and important factors in clinical decision making. #VI541: https://t.co/vAxtKBu1Xr
@WeillCornell_IR @beckcj #IRad #VIR #Interventional
0
5
21
Impact of Radiation Dose & Tumour Burden on Outcomes in HCC 11-Yr Experience in 413 pts Treated with Yttrium-90 Liver Cancer https://t.co/zDkg1E7wfp 👉413 pts, 51.8% beyond up-to-7, 37.3% PVI 👉mOS 20.9 mo 👉Curative conversion 17% > mOS 79.7 mo 🧐Downstaging feasible @myESMO
1
13
39
Read all about Dr Christopher M. Harnain's #ISET2025 presentation on #venous compression syndromes from the ISET Newsroom. https://t.co/NrgE05lK46
@chrisharnain
hmpgloballearningnetwork.com
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
0
4
6
People sure love to complain about physician salaries. You see it everywhere—today was no exception. But here’s what I don’t see: “Thank you for staying up until 3 a.m. to save someone’s life.” “Hey, thanks for taking on $300,000 in debt just to earn the right to take care of
54
120
673
Real world data from the RESIN registry shows better outcomes (OS, TTP, progression free survival) with y90 in the following non CRC metastatic cancers - NEC, breast, sarcoma, prostate, ovarian and renal. @UMMC_Transplant @UMMC_IR @JVIRmedia
jvir.org
To characterize the response and survival outcomes of yttrium-90 (90Y) transarterial radioembolization (TARE) for unresectable, liver-dominant metastases from primary neoplasms other than colorectal...
1
3
10
🤩Super-informative talk by @FAucejo re: #LiverTransplant @ClevelandClinic @CleveClinicFL Cancer Conference. 👉1st liver TXP for met CRC at Cleveland Clinic was 2017. 👉Our approach adds locoregional Rx after systemic Rx prior to TXP. 👉Minimal PET activity pre TXP correlates
0
8
27
Updated data for atezo + bev vs surveillance in resected or ablated high risk HCC #ESMO24 🔎IMbrave050 👉RFS 33.2 vs 36 mo, HR 0.9 👉OS: HR: 1.26 🧐Benefit not sustained! Disappointing.. 🧐Caveat of (too) early read outs… @myESMO #ESMOAmbassadors @ILCA @EASLedu
7
86
183
Knee OA may seem simple, but it's actually highly complex! It results from a combination of mechanical, inflammatory, psychological, and many other factors. Here are 8 specialties that can see and treat these patients. Here's what each of them offer! (*with likely overlap)
1
7
20
🏥 Read "Imaging cholangiocarcinoma: #CT and #MRI techniques," a recent review from Andrea Kierans in @Abdominal_Rad, a publication of @SocietyAbdRad, here 👉 https://t.co/JcfFb3kBgI
0
1
4
Great algorithm on how to treat variceal bleeding in 2024: 🔸Salvage vs preemptive vs rescue TIPS 🔸Management of gastric varices including RTO 🔸Endoscopy, beta-blockers and more https://t.co/OQZDS6Qrbo
@AASLDtweets #livertwitter
0
0
4
Want to know more about selective internal radiation for liver cancer? 1. Study: can downstage! https://t.co/XvoV15FOG8 2. Review: everything you need to know about Y-90 https://t.co/Yk4Qte51nj Both in @HepCommJournal
0
1
4
🆕Article in press❕ Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD #OpenAccess here👉 https://t.co/jxaXaUc3wE
#LiverTwitter
0
25
68
1/6 🚨 Genicular Artery Embolization (GAE) reduces synovitis scores from 5.1±2 to 2.9±2 and provides significant pain relief in knee osteoarthritis patients! 🚑 Just published in @JVIRmedia Learn how GAE can predict pain relief. Dive into the details below! #Osteoarthritis #OA
0
0
11
Online First! Do patients with upper gastrointestinal bleeding and isolated distal deep vein thrombosis benefit from inferior vena cava filters? Huang and colleagues study outcomes of a large cohort of patients managed with and without IVC filters. https://t.co/lAgN1CjaLw
0
0
3
The results were so conclusive that the trial was stopped early for having met predefined stopping rules. @ASCO @SIRspecialists #ASCO2024 #CRC #colorectalcancer #interventionalradiology
radiologybusiness.com
The results were so conclusive that the trial was halted at halftime for having met predefined stopping rules.
0
2
5
Key findings from an RCT comparing thermal ablation to surgery for CRC liver mets. This will further solidify the role of IR in the management of CRC mets @SIRspecialists. Looking forward to reading the full manuscript.
SIR President Robert J. Lewandowski, MD, FSIR, issued a public statement on June 3 welcoming the findings of the Colorectal Liver Metastases: Surgery vs. Thermal Ablation (COLLISION) Trial presented at #ASCO24. Read the full statement: https://t.co/rT0XvwD85C
0
7
33
Nuance for the role of rifaximin 🚫treats overt HE ✅prevents overt HE @AnandVKulkarni2
In the 📕#RedJournal: Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial Kulkarni, et al. 👉 https://t.co/FAueUygSLm
@AnandVKulkarni2 @MLongMD @JasmohanBajaj
1
26
94
🔥 🔥
Boston #IRads collaborated with medical physicists to show that #Y90 radioembolization could be delivered via the bronchial artery for patients with inoperable primary #LungCancer or cancer that has spread into the lungs. #SIR24SLC
0
0
9